20 June 2018
The first Russian intradermal implant has successfully passed the state registration. This product has been developed over the past three years with the support of the Russian Ministry of Industry and Trade as part of the state policy of import substitution.
The original formulation of the product was elaborated by a research company that is resident of Skolkovo Foundation. A unique germanium-organic compound developed under the innovative technology patented in Russia, USA, Europe, Canada, Japan, China, South Korea, and Australia was used as a structure stabilizer. The results of studies showed that, for a number of quality and efficiency indicators, the developed fillers based on hyaluronic acid are not only equal but even superior to many foreign analogs.
Another important factor is affordable competitive price of the final product. First serial lot of the product is being prepared for the launch in the Russian market that is expected to occur at the end of this August. The immediate plans of the manufacturer include launching to the Russian market several more innovative cosmetic and medicinal products that have no analogs in the world.
Print14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
Russian drug for the treatment of viral hepatitis will be exempt from duty in Mongolia
24 April 2024
PM Mishustin: “We need to increase the production of vital and essential drugs in Russia”
24 April 2024
The Future of Pharmacy: How Advancements in Technology Are Transforming the Field
23 April 2024
Analysis Forecasts Up to 16.5% of Population Will Have Chronic Kidney Disease by 2032
23 April 2024